BCM
MED icon

Brookstone Capital Management’s Medifast MED Stock Holding History

Brookstone Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,142
Closed -$209K – 853
2023
Q1 		$209K Sell
2,142
-818
-28% -$90.7K ﹤0.01% 778
2022
Q4 		$354K Sell
2,960
-1,212
-29% -$141K 0.01% 664
2022
Q3 		$504K Buy
4,172
+162
+4% +$23.2K 0.01% 563
2022
Q2 		$707K Buy
4,010
+2,775
+225% +$496K 0.02% 493
2022
Q1 		$225K Sell
1,235
-610
-33% -$115K ﹤0.01% 706
2021
Q4 		$396K Buy
1,845
+82
+5% +$16.9K 0.01% 567
2021
Q3 		$336K Buy
1,763
+30
+2% +$7.38K 0.01% 576
2021
Q2 		$479K Buy
+1,733
New +$470K 0.01% 489

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return